<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81">
 <label>81</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hatat</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Yahiaoui</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lecoutey</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A novel in vivo anti-amnesic agent, specially designed to express both acetylcholinesterase (AChE) inhibitory, serotonergic subtype 4 receptor (5-HT4R) agonist and serotonergic subtype 6 receptor (5-HT6R) inverse agonist activities, With a Potential Interest Against Alzheimerâ€™s Disease</article-title>
  <source>
   <italic toggle="yes">Frontiers in Aging Neuroscience</italic>
  </source>
  <year>2019</year>
  <volume>11</volume>
  <pub-id pub-id-type="doi">10.3389/fnagi.2019.00148</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85069174352</pub-id>
 </element-citation>
</ref>
